• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.29% Nasdaq Down 3.25%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    4.81 Down 0.07(1.43%) Feb 5, 4:00PM EST
    |After Hours : 4.82 Up 0.01 (0.21%) Feb 5, 7:59PM EST
    Prev Close:4.88
    Open:4.82
    Bid:4.81 x 100
    Ask:4.82 x 100
    1y Target Est:16.35
    Beta:1.8243
    Earnings Date:Feb 24 - Feb 29 (Est.)
    Day's Range:4.51 - 4.86
    52wk Range:4.08 - 15.01
    Volume:17,731,815
    Avg Vol (3m):6,851,490
    Market Cap:1.30B
    P/E (ttm):N/A
    EPS (ttm):-0.43
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVAX

    Comparison

    Symbol% ChgMkt Cap
    NVAXDown 1.43%1.30B
    MRKUp 1.63%137.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.48
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.44
    Quarterly EPS Est (Dec-15) :-0.14
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback